Best of Tressless Roundup

May 2026 – First Half

In androgenetic alopecia, stress exacerbates prevalence among medical students, while genetics and hormones drive female cases, with treatments targeting drugs and new therapies; the PCOS link involves insulin resistance and inflammation, and dyslipidemia and hormonal profiles in men suggest lipid metabolism connections. Innovations include hydrogel-based organoids for drug testing and bubble microneedles for drug delivery. Platelet-rich plasma with systemic therapies enhances outcomes, and Minoxidil remains key, with New Hair4U Solution showing promise. Nutraceuticals like gummy supplements and herbal oils offer alternatives, while Biochanin A from soy targets the SRD5A2/AR/beta-catenin axis. Scalp microbiota studies in seborrheic alopecia show herbal shampoos improve scalp health. Stress lacks significant correlation with hair loss in medical students, but particulate matter links to postpartum hair loss. In alopecia areata, Australian prevalence studies and systematic reviews explore skin cancer risk, while the COVID-19 pandemic has increased cases and hospitalizations.

The community buzzes with discussions on hair loss treatments, weighing the shift from oral to topical solutions like dutasteride and minoxidil due to systemic concerns, while some consider switching from finasteride to dutasteride for better results. Concerns about DHT blockers affecting facial bone growth spur interest in topical alternatives. Combination treatments involving minoxidil, laser caps, and topical finasteride are evaluated, with hair transplants as a complementary strategy. The efficacy of microneedling and tretinoin in boosting minoxidil absorption is explored, alongside worries about counterfeit minoxidil. Experiences with hair transplants highlight the need for reputable clinics, addressing chronic hair loss despite varied treatments. Oral minoxidil is considered for those with limited topical success, with advice on minoxidil foam dosage and application to enhance regrowth. Financial constraints prompt discussions on affordable solutions, sharing insights on maintaining hair health post-transplant and during treatment shifts. The role of ketoconazole shampoo and RU58841 in regrowth routines is scrutinized, as users aim to balance efficacy, safety, and cost.

June 2026 – First Half

Research in hair loss and regrowth explores herbal hair serums and shampoos with natural ingredients like rosemary extract, rivaling minoxidil, while polyherbal oils with bhringraj and amla reduce hair fall. Non-surgical methods such as Jet Peel technology and solid microneedle boosters enhance hair density, with exosomes from salmon tissue and iontophoresis targeting androgenetic alopecia. Pharmacological studies compare finasteride and dutasteride, while quercetin and kaempferol inhibit Jak3 kinase and 5-alpha reductase type II. Advances in stem cell-based therapies and immune-competent hair follicle systems offer targeted treatments, with the M5 isolation method preserving dermal papilla cells’ trichogenic identity. The role of vitamin D in non-scarring alopecia and GLP-1 receptor agonists on hair loss highlights broader physiological factors affecting hair health.

The community intensely debates hair loss treatments, scrutinizing finasteride’s cognitive and emotional effects and side effects prompting shifts to dutasteride or topical alternatives to mitigate dizziness. Concerns about dutasteride-induced shedding and generic drug legitimacy abound, with hormonal monitoring via testing advised. Managing hair loss during steroid cycles and post-finasteride syndrome risks are pivotal. Users share experiences with RU-58841 and GHK-Cu, debating RU-58841 and oral minoxidil combinations due to heart-related side effects. Microneedling and tretinoin with minoxidil are explored for enhanced results. Advice is sought on fluridil side effects and hair transplant outcomes. The effectiveness of ketoconazole and contact reactions from topicals are discussed in the quest for solutions.